✦ LIBER ✦

Deferasirox effectively decreases iron burden in patients with double heterozygous HbS/β-thalassemia

✍ Scribed by Ersi Voskaridou; Eleni Plata; Marousa Douskou; Anastasia Sioni; Efrosini Mpoutou; Dimitrios Christoulas; Maria Dimopoulou; Evangelos Terpos

Book ID: 105989672
Publisher: Springer
Year: 2010
Tongue: English
Weight: 136 KB
Volume: 90
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-010-1029-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with deferasirox (Exjade®) eff

Treatment with deferasirox (Exjade®) effectively decreases iron burden in patients with thalassaemia intermedia: results of a pilot study

✍ Ersi Voskaridou; Eleni Plata; Maroussa Douskou; Manousos Papadakis; Eleni-Evange 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Deferasirox (Exjade®) significantly impr

Deferasirox (Exjade®) significantly improves cardiac T2* in heavily iron-overloaded patients with β-thalassemia major

✍ Anil Pathare; Ali Taher; Shahina Daar 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 126 KB

Recurrent pulmonary thromboembolism in a

Recurrent pulmonary thromboembolism in a patient with heterozygous β-thalassemia with Hb E state: A rare complication

✍ Sunil Gupta; Meenal Gupta; Madhulika Kabra; Renu Saxena; Ved Prakash Choudhry 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

Prospective evaluation of patient-report

Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with β-thalassemia

✍ Maria Domenica Cappellini; Mohamed Bejaoui; Leyla Agaoglu; John Porter; Thomas C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 628 KB

IRON CHELATION THERAPY WITH DEFERASIROX

IRON CHELATION THERAPY WITH DEFERASIROX (EXJADE®) IN REDUCING CARDIAC SIDEROSIS IN β-THALASSEMIA PATIENTS: 2-YEAR RESULTS FROM THE EPIC CARDIAC SUBSTUDY

✍ Dudley J. Pennell; John Porter; Domenica Cappellini; Lee Lee Chan; Amal El-Beshl 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Achieving treatment goals of reducing or

Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with β-thalassaemia: results from the ESCALATOR study

✍ Ali Taher; Mohsen S. Elalfy; Kusai Al Zir; Shahina Daar; Abdullah Al Jefri; Dany 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB